The International Journal of Nano Dimension is a premier publication dedicated to advancing the field of nanotechnology and its applications across various disciplines, published by the Islamic Azad University, Tonekabon Branch. With an ISSN of 2008-8868 and an E-ISSN of 2228-5059, this journal serves as a vital platform for researchers, professionals, and students seeking to disseminate and access cutting-edge findings in nano materials and their integration into science and engineering. The journal has gained notable recognition in Scopus rankings, especially within the fields of Materials Science and Chemical Engineering, emphasizing its commitment to high-quality research. Spanning the years from 2019 to 2024, the journal emphasizes open access to foster knowledge sharing in the scientific community. As nanotechnology continues to revolutionize industries, the International Journal of Nano Dimension plays an essential role in showcasing transformative research that addresses the challenges and opportunities of this dynamic field.

Materials Today Bio, published by Elsevier, is an esteemed open-access journal dedicated to advancing the fields of bioengineering, biomaterials, and biomedical engineering. Since its inception in 2019, this journal has quickly made a name for itself, currently ranked Q1 in multiple categories including Bioengineering, Biomaterials, and Biotechnology, reflecting its exceptional quality and relevance in the rapidly evolving landscape of bio-related sciences. With an impressive Scopus ranking positioning it in the top 25% of its categories, Materials Today Bio provides a vital platform for researchers and professionals to share cutting-edge discoveries and innovative applications that bridge the gap between materials science and biological studies. Accessible to a global audience, this journal not only fosters collaboration among the scientific community but also aims to highlight significant advancements in cell and molecular biology, making it an indispensable resource for students and seasoned experts alike. The journal's commitment to open access since 2019 underscores its dedication to disseminating knowledge widely, ensuring that crucial findings reach those who can benefit from them the most.

Nanotechnology Reviews, published by DE GRUYTER POLAND SP Z O O, stands at the forefront of the multidisciplinary field of nanoscience and nanotechnology. With an Open Access model adopted since 2019, this journal, identifiable by its ISSN 2191-9089 and E-ISSN 2191-9097, disseminates vital research that is accessible to a global audience. The journal is located in Germany and has established itself as a premier platform for innovative research, boasting impressive quartile rankings: Q1 across several categories including Biotechnology, Energy Engineering, and Materials Science, as well as a Q2 classification in Biomaterials as of 2023. The diverse scope enables authors to contribute to a range of topics, from biomedical applications to energy solutions and advanced materials, making it essential reading for researchers, professionals, and students passionate about cutting-edge developments. Additionally, with Scopus rankings highlighting its value across various domains and robust percentiles, including 94 in Engineering (miscellaneous), 93 in Medicine (miscellaneous), and 88 in Biotechnology, Nanotechnology Reviews is an influential and respected journal that fosters scientific dialogue and innovation.

Nature Nanotechnology, published by NATURE PORTFOLIO, stands at the forefront of scientific innovation, focusing on the rapidly evolving field of nanoscience and nanotechnology. With an impressive impact factor and ranking in the top Q1 quartiles across multiple disciplines—including Atomic and Molecular Physics, Bioengineering, and Materials Science—this journal is a pivotal resource for researchers and professionals dedicated to advancing knowledge and applications at the nanoscale. Its diverse scope encompasses cutting-edge research that bridges disciplines, addressing critical challenges in engineering, physics, and biomedical fields. Although the journal currently does not offer an open-access option, readers can access a wealth of information that is vital for anyone involved in pioneering research and development efforts. With its robust editorial standards and a commitment to publishing high-caliber, groundbreaking work, Nature Nanotechnology serves as an indispensable platform for the dissemination of transformative ideas that will shape the future of technology and science.

Artificial Cells Nanomedicine and Biotechnology is a prestigious peer-reviewed journal published by TAYLOR & FRANCIS LTD, specializing in the rapidly evolving fields of biomedical engineering, biotechnology, and nanomedicine. Established in 2013 and operating under an open-access model since 2019, the journal aims to bridge the gap between fundamental science and real-world medical applications, showcasing cutting-edge research that advances our understanding of artificial cells and their biotechnological applications. With an impressive impact factor and ranking in the Q2 quartile across various categories, including Biomedical Engineering, Medicine, and Pharmaceutical Sciences, the journal is a leading platform for innovative studies that contribute significantly to the realm of healthcare and therapeutic development. Researchers, professionals, and students alike will find invaluable insights and advancements within its pages, positioning it as a vital resource for those dedicated to pushing the boundaries of science and improving patient outcomes.

Nanofabrication is a leading open-access journal dedicated to advancing the field of nanotechnology through innovative research and comprehensive reviews. Published by the Eurasia Academy Publishing Group (EAPG) since 2014, this journal aims to provide a platform for academic discourse, promoting the latest insights and findings in nanofabrication techniques and applications across diverse domains, including materials science, electronics, and drug delivery systems. With a commitment to accessibility, Nanofabrication ensures that all content is freely available to researchers, professionals, and students worldwide, thereby fostering collaboration and knowledge sharing in the rapidly evolving landscape of nanotechnology. The journal's emphasis on high-quality, peer-reviewed research positions it as an authoritative source for those looking to stay at the forefront of developments in the field.

Advanced NanoBiomed Research is a pioneering open-access journal committed to advancing the interdisciplinary field of nanobiotechnology, published by WILEY-V C H VERLAG GMBH. Since its inception in 2021, this journal has provided a platform for innovative research that bridges the gap between engineering, medicine, and materials science. With impressive rankings in Scopus, positioning it within the top quartiles of various categories, Advanced NanoBiomed Research aims to disseminate high-quality research that contributes to the understanding and application of nanomaterials in biomedical contexts. As it encompasses a wide scope—from applied microbiology to biomaterials—it serves as an essential resource for researchers, professionals, and students eager to explore the cutting-edge developments in the field. The journal promotes a collaborative environment where emerging ideas can flourish, ensuring that vital advancements in nanobiomedicine can be shared and built upon within the scientific community.

JOURNAL OF DRUG TARGETING, published by Taylor & Francis Ltd, is a premier academic journal dedicated to advancing the field of pharmaceutical sciences with a strong focus on drug delivery and targeting methodologies. With an impressive impact factor and recognized as a Q1 journal in the Pharmaceutical Science category, it ranks #23 out of 183 in Pharmacology, Toxicology and Pharmaceutics, placing it within the top 13% of journals in its field. The journal provides a platform for interdisciplinary research, showcasing innovative techniques and breakthrough findings that serve to improve therapeutic efficacy through precision targeting. Although it operates under a subscription model, researchers benefit from extensive access to pivotal studies spanning from 1986 to 2024. The JOURNAL OF DRUG TARGETING aims to foster collaboration among academics, professionals, and students, making it an essential resource for those seeking to leverage the latest advancements in drug development and delivery systems for improved healthcare outcomes.

The Journal of Nano Research, published by Trans Tech Publications Ltd, is a distinguished academic journal dedicated to the rapidly evolving field of nanotechnology and materials science. With an ISSN of 1662-5250 and an E-ISSN of 1661-9897, the journal has been an important platform for researchers and professionals since its inception in 2008, continuing to provide high-quality peer-reviewed research through to 2024. Nestled in Switzerland, the Journal of Nano Research plays a pivotal role in disseminating cutting-edge findings, as recognized by its categorization in Q3 for Materials Science and Physics while being positioned in Q4 for Nanoscience and Nanotechnology as of 2023. With Scopus rankings highlighting its impact, including Rank #129 in general Physics and Astronomy and Rank #300 in Materials Science, this journal is crucial for academics seeking to stay ahead in research trends and innovations in nano-related disciplines. Although it operates under a subscription model, the journal's objectives include fostering collaboration and knowledge-sharing among researchers, making it an invaluable resource for anyone immersed in the world of nanotechnology.

International Journal of Pharmaceutics-X is a premier open access journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmaceutical sciences. Launched in 2019, this journal has quickly ascended to the Q1 category in the 2023 Category Quartiles, reflecting its high impact and the quality of research it promotes. With a current Scopus ranking of #49 out of 183 in the Pharmacology, Toxicology and Pharmaceutics category, this journal occupies the 73rd percentile, showcasing its significant influence within the scholarly community. Emphasizing innovative research and novel applications, the International Journal of Pharmaceutics-X offers a platform for researchers, professionals, and students to disseminate their findings, making crucial contributions to the global pharmaceutical landscape. The journal is based in the Netherlands, presenting a vibrant hub for scientific discourse and collaboration in a rapidly evolving field.